Lionco Pharmaceutical Group (SHA:603669) said one of its drugs, huperzine A for injection, was selected in the alliance drug procurement of China's Henan Province, according to a Shanghai bourse filing on Thursday.
The drug is used to improve the memory, associative learning and other abilities of patients with dementia and other brain disorders.
The pharmaceutical company's shares rose 1% at the close.